Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3634221000168114 | Dilasig 12.5 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3634231000168112 | Dilasig (carvedilol 12.5 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dilasig 12.5 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Dilasig 12.5 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Dilasig 12.5 mg tablet | Is a | Dilasig | true | Inferred relationship | Some | ||
| Dilasig 12.5 mg tablet | Is a | carvedilol 12.5 mg tablet | true | Inferred relationship | Some | ||
| Dilasig 12.5 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Dilasig 12.5 mg tablet | has Australian BoSS | carvedilol | true | Inferred relationship | Some | 1720021600 | |
| Dilasig 12.5 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1720021601 | |
| Dilasig 12.5 mg tablet | has intended active ingredient | carvedilol | true | Inferred relationship | Some | 1720021600 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dilasig 12.5 mg tablet, 60 | has TPUU | True | Dilasig 12.5 mg tablet | Inferred relationship | Some | 1 |
| Dilasig 12.5 mg tablet, 60, blister pack | has TPUU | True | Dilasig 12.5 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR